Securities code: 000504 securities abbreviation: Nanhua Bio-Medicineco.Ltd(000504) Announcement No.: 2022-007
Nanhua Bio-Medicineco.Ltd(000504)
Announcement on the resolution of the second meeting of the 11th board of supervisors
The company and all members of the board of supervisors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Meetings of the board of supervisors
The second meeting of the 11th board of supervisors of Nanhua Bio-Medicineco.Ltd(000504) (hereinafter referred to as “the company”) is scheduled to be held by means of communication voting on January 25, 2022. The notice of the meeting was sent to all supervisors of the company by email and SMS on January 21, 2022. There are 3 supervisors who should participate in voting at the meeting and 3 supervisors who actually participate in voting. The meeting is held in accordance with the relevant provisions of the company law and the articles of association, and is legal and effective.
2、 Deliberation of the proposal of the board of supervisors
1. Proposal on the remuneration scheme of the company’s supervisors
The board of supervisors of the company believes that the remuneration plan of the company’s supervisors formulated by the company in accordance with the provisions of the company law, the guidelines for the governance of listed companies and other relevant laws and regulations and the articles of association is conducive to further improving the level of corporate governance, promoting the healthy and sustainable development of the company and in line with the actual situation of the company.
The meeting deliberated the proposal on the remuneration scheme of the company’s supervisors, and the voting results were: 0 in favor, 0 against, 0 abstention and 3 avoidance.
In view of the interest relationship between this proposal and all supervisors, all supervisors avoid voting and directly submit it to the general meeting of shareholders of the company for deliberation.
The details of the above matters are detailed in the remuneration plan for directors, supervisors and senior managers disclosed by the company on the same day.
2. Proposal on purchasing directors, supervisors and senior managers liability insurance
The board of supervisors of the company believes that the purchase of directors, supervisors and senior managers’ liability insurance is conducive to improving the company’s risk management system, promoting the full performance of the company’s directors, supervisors and senior managers, and protecting the interests of the company and all shareholders.
The meeting considered the proposal on purchasing the liability insurance of directors, supervisors and senior managers, and the voting results were: 0 in favor, 0 against, 0 abstention and 3 avoidance votes.
In view of the interest relationship between this proposal and all supervisors, all supervisors avoid voting and directly submit it to the general meeting of shareholders of the company for deliberation.
For details of the above matters, see the announcement on purchasing directors, supervisors and senior executives liability insurance disclosed by the company on the same day.
3、 Documents for future reference
The resolution of the board of supervisors signed and sealed by the attending supervisors.
It is hereby announced.
Nanhua Bio-Medicineco.Ltd(000504) board of supervisors January 26, 2022
